Acenxion Biosystems

Acenxion Biosystems specializes in providing diagnostic solutions focused on rapid antimicrobial susceptibility testing (AST). The company partners with public health laboratories, hospitals, clinics, and healthcare professionals to deliver phenotypic AST results within 4 to 6 hours, significantly reducing the time compared to traditional methods. This expedited process helps combat antibiotic resistance, lowers hospital costs, and improves patient outcomes by enabling timely and effective treatment decisions. Acenxion's business model revolves around leveraging advanced diagnostic technology to address the critical issue of antibiotic resistance, a growing global health concern. The company generates revenue by offering its diagnostic services to healthcare institutions that require efficient and accurate AST results. By focusing on the healthcare sector, Acenxion serves a market that demands reliable and swift diagnostic solutions to improve patient care and reduce mortality rates associated with infections like sepsis.

Keywords: antimicrobial, susceptibility, testing, diagnostics, healthcare, laboratories, hospitals, clinics, resistance, sepsis.